Experience with extracorporeal membrane oxygenation in children more than one month old.
Extracorporeal membrane oxygenation (ECMO) has been used at the Royal Children's Hospital, Melbourne, in the treatment of children with life-threatening respiratory or cardiac failure since May 1988. The main indications for its use are, first, the disease is thought to be reversible, second, the child will survive with an acceptable quality of life and, third, the child has an 80% chance of dying without ECMO. Seven of eighteen children receiving ECMO have survived to leave hospital, and all are functionally normal: these results are similar to international results. It would appear that ECMO is a useful therapy for some children with otherwise fatal cardiorespiratory failure.
Butt
W
W
Intensive Care Unit, Royal Children's Hospital, Melbourne, Victoria, Australia.
Karl
T
T
Horton
A
A
Shann
F
F
Mullaly
R
R
D000293:Adolescent; D002303:Cardiac Output, Low / Q000628:therapy*; D002648:Child; D002675:Child, Preschool; D015199:Extracorporeal Membrane Oxygenation; D006801:Humans; D007223:Infant; D012131:Respiratory Insufficiency / Q000628:therapy*